As of Aug 27
| +3.66 / +6.27%|
The 15 analysts offering 12-month price forecasts for Imperva Inc have a median target of 80.00, with a high estimate of 88.00 and a low estimate of 67.00. The median estimate represents a +29.03% increase from the last price of 62.00.
The current consensus among 18 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.